Maxcyte (MXCT) Non-Current Deffered Revenue (2021 - 2022)
Maxcyte (MXCT) posted Non-Current Deffered Revenue of $344,600 for Q3 2022.
Powered by 
Analysis
Maxcyte (MXCT) Non-Current Deffered Revenue (2021 - 2022) Analysis & Trends
At the end of FY2021, Maxcyte's Non-Current Deffered Revenue came in at $450,200.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | - |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | - |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | - |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | - |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | - |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | - |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | - |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | - |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | - |
| 10 | Maxcyte | 118.87 Mn | 118.87 Mn | 5.60 Mn | - |
API Access
Maxcyte Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MXCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "MXCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=MXCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();